“…Given that acetylcholine (ACh) mediates reward, 1,2 learning, memory, and other higher‐order cognitive processes, 3 the cholinergic system is an appealing pathway to target for the treatment of neuropsychiatric disorders, including addiction. Recently, we have implicated both the M 4 and M 5 muscarinic acetylcholine receptors (mAChRs) in alcohol consumption and seeking 4‐7 . However, little research has focused on M 1 mAChRs in drug and alcohol use disorders (AUD), with a primary focus surrounding cognition, including in Alzheimer's disease (AD), Parkinson's disease (PD), and schizophrenia 8‐10 …”